Pembrolizumab and Its Side Effects: A Scientific Review and Clinical Applications in Various Cancers
IntroductionPembrolizumab, commercially known as Keytruda, is an immunotherapy widely used in the treatment of various cancers. It is a monoclonal antibody that works by inhibiting the PD-1 (Programmed Death-1) receptor on T cells, which cancer cells typically exploit to evade the immune system. By blocking this receptor, pembrolizumab enhances the immune system’s ability to recognize…
Pembrolizumab Cancer Drugs: A Breakthrough in Modern Oncology
Pembrolizumab Cancer Drugs. In the realm of oncology, the advent of immunotherapy has revolutionized the treatment landscape, offering hope where traditional therapies often fall short. Among these cutting-edge treatments, Pembrolizumab has emerged as a front-runner, particularly in the fight against various types of cancer. Marketed under the brand name Keytruda, Pembrolizumab is a monoclonal antibody…
Glp 1 agonists: diabetes drugs and weight loss
Drugs meant for diabetes treatment are now helping fight obesity. Glucagon-like peptide-1 (GLP-1) agonists are used for type 2 diabetes. They’re now seen as key in losing weight for those who are overweight. This new use has sparked a lot of interest and research in the medical field. Key Takeaways Understanding GLP-1 Agonists GLP-1 agonists, also known as incretin…
